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Abstract 
 
Background: Missing data is a common problem in cancer research. While simple methods such as complete-
case (C-C) analysis are commonly employed for handling this problem, several studies have shown that these 
methods led to biased estimates. We aim to address the methodological issues in development of a prognostic 
model with missing data. 
 
Methods: Three hundred and ten breast cancer patients were enrolled. At first, patients with missing data on any 
of four candidate variables were omitted. Secondly, missing data were imputed 10 times. Cox regression model 
was fitted to the C-C and imputed data. Results were compared in terms of variables retained in the model, 
discrimination ability, and goodness of fit. 
 
Results: Some variables lost their effect in complete-case analysis, due to loss in power, but reached significance 
level after imputation of missing data. Discrimination ability and goodness of fit of imputed data sets model was 
higher than that of complete-case model (C-index 76% versus 72%; Likelihood Ratio Test 51.19 versus 32.44).  
 
Conclusion: Our findings showed inappropriateness of ad hoc complete-case analysis.  This approach led to 
loss in power and imprecise estimates. Application of multiple imputation techniques to avid such problems is 
recommended. 
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Introduction 
 
Prognostic models combine key patient characteris-
tics (risk factors) to predict clinical outcomes such as 
recurrence of cancer. These models are excellent tools 
to investigate the contribution of variables to disease 
course, and to select the appropriate treatment paths.
1   
However, if in development of model, one ignores 
model assumptions, results might be misleading.
2,3 
One of the issues that challenge the modelling prac-
tice is incomplete data. A problem in survival analy-
sis occurs when data are missing on risk factors.
4 The 
traditional response to this problem is to exclude in-
dividuals with incomplete data on any prognostic fac-
tors from analysis (Known as Complete-Case Analy-
sis (C-C analysis).
4  
However, exclusion of missing data leads to attri-
tion in sample size which will diminish precision of 
estimates and can lead to biased estimates.
5,6 There-
fore, appropriate methods should be applied to impute 
missing data. Methodological developments in the 
filed of analysis of missing data offers a lot to model-
ling. Advanced likelihood-based methods can be ap-
plied to use partially observed data so as to predict 
missing values. This preserves attrition in sample size 
and avoids biased estimates.  
There are lots of methods to tackle the problem of 
missing data. The main aim of this paper is to high-
light the methodological issues in development of a 
prognostic model in presence of missing data. Here 
we only focused on the Multivariable Imputation via 
Chained Equations (MICE) method. The MICE is a 
flexible method which has the capability to deal with 
all forms of variables (continuous, categorical, and 
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binary), and can be used in regression settings. Meth-
ods were applied analysing a breast cancer data set. 
To show the power of the MICE method in recovery 
of information, prognostic models were developed 
using complete data as well as imputed data sets. 
 
 
Materials and Methods 
 
From 1994 to 2003, the information of 310 breast 
cancer patients in Shiraz (located in southern Iran) 
with a median follow-up of 2.5 years, were collected 
from Hospital-based Cancer Registry of Nemazee 
Hospital (affiliated to Shiraz University of Medical 
Sciences). The end point of the study was death. At 
the end of the study, there had been 56 deaths.  
Variables offered to the multifactorial models were 
those showed to have univariate predictive ability (tu-
mor stage with 3 levels (early, locally advanced, and 
advanced), tumor grade with 3 levels (1, 2 and 3), his-
tory of benign breast disease (positive versus negative), 
and age at diagnosis (≤47 versus >47).
7 The data set do 
not include personal information such as name, ad-
dress, or phone number of patients. 
For analyzing of data, Kaplan-Meier and Log-rank 
tests were used to compare the survival curves in differ-
ent groups. Linear Cox model was then applied to de-
velop the multifactorial regression models and to esti-
mate Hazard Ratios (HR).
8 Two models were used us-
ing Complete-Case (C-C) data and imputed data sets. To 
impute the missing data, Multivariable Imputation via 
Chained Equations were applied (MICE model). 
In the C-C model, patients with missing data on 
any of 4 variables selected were excluded. Cox re-
gression model in conjunction with ENTER variable 
selection method was then fitted to patients with 
available data on all 4 candidate risk factors. A final 
risk score was calculated by multiplying variables 
into the estimated regression coefficient. Tertiles of 
the risk score estimated were applied as cut off to cat-
egorise patients into low (L), intermediate (I), and 
high (H) risk groups. 
The MICE method is a probabilistic approach. The 
usual practice to reflect the uncertainty about the true 
values of the missing data, is to replace each missing 
value by 10 values leading to 10 imputed data sets.
9,10  
The process of the MICE method is described below: 
To identify the mechanism of missing data, an in-
dicator variable for each of variables which had miss-
ing data was created. For example, indicator variable 
for stage variable shows whether patient had missing
value or not. Patients with available data get a value 
of 1 while others get 0. The association between this 
indicator variable, showing stage missing and rest of 
variables were assessed applying Chi-Square test. 
When the missingness depends on observed variables 
mechanism, it is called Missing At Random (MAR). 
  It has been suggested that, for best imputation, the 
outcome variable should be included in the imputa-
tion model.
11 Therefore, patients' outcome and set of 
four risk factors were used in the MICE algorithm. 
Polytomous and logistic regression were used to 
impute missing data for categorical (stage and grade) 
and binary data (age and benign disease history) re-
spectively.  
The MICE method involves no distributional as-
sumption and can be used to impute missing data for 
continuous, categorical, and binary variables. To im-
pute missing value on a variable which include miss-
ing data, say  j X , a regression model relates  j X  to 
other variables in the imputation model. This regres-
sion model is then used to create imputed values by 
drawing from the posterior predictive distribution. 
Each predictor with missing values is considered in 
turn using the current imputed values for each of the 
other predictors.
12 The iteration process ends when all 
variables had been updated technical details are given 
in Appendix.
13,14 This entire process was repeated and 
the imputed values which are created at the 5
th round 
were used as the first imputed data set. The whole 
processes were repeated 10 times to replace each 
missing data by 10 values, thus creating 10 data 
sets.
12  The standard algorithm imputes each incom-
plete column in the data from left to right. It is known 
that this issue (i.e. order of the variables) is essential-
ly irrelevant to the results. 
The creation of 10 data sets means there is a re-
quirement for 10 modelling analyses, one for each data 
set, and there will therefore be 10 different estimates for 
each parameter. Estimates derived from imputed data 
sets (the coefficients and standard errors) therefore, need 
to be combined and this was achieved applying Rubin’s 
rule.
14 The final regression coefficient is simply the av-
erage of coefficients across imputed data sets.
14 In esti-
mation of standard errors, both between and within im-
putation variations should be taken into account tech-
nical details are given in Appendix.  
Hazard Ratios (HR) and corresponding 95% Con-
fidence Intervals (C.I.) were calculated from regres-Baneshi et al. 
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sion coefficients and standard errors that have been 
imputed across multiply imputed data sets.  
A risk score was calculated for each of 10 imputed 
data sets. For each patient, a single averaged risk 
score was calculated by averaging her estimated risk 
scores from each of the 10 imputed data sets. 
In risk stratification studies, it is important to cre-
ate risk groups where patients in each group are 
equally likely to develop the outcome.
15 Discrimina-
tion refers to the ability to separate patients with dif-
ferent responses
15 and is measured using Harrell’s C-
index (concordance index) which is a generalisation 
of Area Under Curve (AUC).
16,17 The C-index is in-
terpreted as correct ordering in the sense that compar-
ing risk predictions for two patients, risk calculated 
for whom developed the disease is higher than the 
other one. This statistic varies between 0.5 and 1 
where values near 1 indicate high discrimination 
power. However, if performance is assessed on the 
same sample as used for model development, then 
performance will be overestimated. Therefore, boot-
strap procedure was applied and bias-corrected C-
indices were reported.
18  
For all models, we will report Likelihood Ratio 
Test (LRT) which indicates how well the model fits 
the data. A series of packages which work under R 
software (version 2.5.1) were used.
19 Missing data 
were imputed using MICE package. Estimated re-
gression coefficients and standard errors were com-
bined across imputed data sets using Mitools library. 
Performance of models (discrimination and predictive 
ability) was assessed using Design library. K-M 
curves are plotted using SPSS software. 
 
 
Results 
 
Information for age variable was available for all pa-
tients. The variables nodal status and grade involved 
about 20% missing rate (20.3% and 20.6% respec-
tively). Corresponding figure for 'history of benign 
disease' was 15.2%. However, after exclusion of 
missing data on all four variables, 35% of data were 
lost. Totally, 203 cases (65%) had data available on 
all 4 variables. Almost all patients with missing data 
were those survived. Out of 56 deaths only 2 ones 
were lost in complete-case analysis.  
We first examined missing data mechanism (Table 1). 
As shown, patient's status, grade and history of be-
nign disease can predict missingness on stage varia-
ble. Patients' status and history of benign disease were 
predictors of grade missing. Furthermore, patients' 
status and age at diagnosis were predictors of benign 
disease variable. This confirms that data had a Miss-
ing At Random (MAR) mechanism.     
Estimated Hazard ratios (HR) with 95% Confi-
dence Intervals (C.I.), corresponding to complete-case 
and imputed data sets are given in Table 2. Age at 
diagnosis and history of benign disease were not sig-
nificant in complete-case model, due to attrition in 
sample size and inevitable loss in power of model. 
Furthermore, risk of death for patients with stage 3 
relative to those with stage 1 was not significant in 
complete-case model. After imputing missing data, 
both of these variables (age at diagnosis and family 
history of benign disease) were retained in the model. 
In addition, HR for cases with stage 3 relative to stage 
1 reached a significance level. 
Comparing performance of models, imputation of 
missing data led to 4 percentages point improvement in 
discrimination ability of model (76% for the MICE ver-
sus 72% for C-C data). Furthermore improvement in 
model goodness of fit was seen (51.19 versus 32.44).  
 
 
Discussion 
 
Missing data are a common problem in medical and 
epidemiological data sets. Exclusion of missing data 
leads to loss of power. In results presented, some var-
iables lost their significant effect in complete-case 
analysis. For example, stage of disease is known as 
one of the most important prognostic variables.
20,21 
However, this variable did not reach to the significant 
level in the C-C model.  
On the other had, in order to protect against 
chance effects dues to imputation, we imputed 10 da-
ta sets. This protection was to be felt worth the   
Table 1: Investigation of the association between variables' missingness and the rest of variables
a 
Missing indicator Status  Stage Grade Benign  disease  Age
Stage +    +  +  - 
Grade +  -  + - 
Benign disease  +  -  -    + 
a +: association between missing indicator and variable, -: lack of association between missing indicator and variable Survival models on breast cancer 
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inconvenience of having to average risk scores across 
10 final models. Once missing data were imputed, 
power was increased and variables lost their effect in 
complete-case model (such as stage of disease) and 
reached a significance level.  
We also showed that our data had a Missing At 
Random (MAR) mechanism. This means that missing 
data depends on other patients' characteristics and 
therefore can be well imputed using multiple imputa-
tion methods. We should emphasize that our main 
goal was to illustrate the process of development of a 
prognostic model when missing data exist. To 
achieve this, we simply used a breast cancer data set 
in southern Iran as a prevalent cancer in this region 
set as an example.
22,23 Discussion of risk factors of 
breast cancer is beyond the scope of this paper and 
were previously reported.
22,23 This issue has been ad-
dressed here.
20,21 
It should be noted that, when missing rate is low, 
results of C-C model, in terms of variables retaining 
in the final model, might be similar to that of MICE. 
Asia Pacific Cohort Studies Collaborators (APCSC) 
collects data to determine Coronary Heart Disease 
(CHD) risk factor. Ability of multiple imputation and 
complete-case analysis to handle the missing data on 
a single variable (cholesterol) in 26 studies was com-
pared.
24 Cholesterol missing rate varied from 0% to 
69%. In 22 studies where cholesterol value was not 
available for about 10% of subjects both methods 
gave similar results. On the other had, in four studies 
with missing rate between10% to 60%, clear differ-
ence was seen between models. It has also been 
commented that with more than 60% missing rate, the 
MICE model might not provide accurate estimates.
24   
  However, we believe that a low rate of missing 
data on each variable might cause serious problems in 
multivariate modelling when patients with missing 
data on different variables are not the same because 
this might substantially reduce the number of com-
plete cases available for analysis, and increase the 
chance of bias due to excluded cases.  
We developed the multifactorial models in con-
junction with ENTER variable selection method. 
When Backward Elimination (B.E.) variable selection 
is hired, a series of iterative steps are required to ex-
clude variables which do not contribute significantly 
to the model. If a single multifactorial model was de-
veloped, then application of B.E. is straightforward. 
However, when there are 10 imputed data sets, B.E. 
will not directly be feasible. In an iterative process, at 
each step, the results were aggregated across the 10 
data sets, and the variable with the highest P-value 
(exceeding 0.05) was removed. Another set of 10 
models were fitted with remaining variables, results 
were aggregated, and P-value assessed for a variable 
to drop (if p-value >0.05). The whole process contin-
ued until all variables remained significant.
12,13  
Before development of multifactorial models, we 
dichotomised the variable age at 48 because we 
showed that dichotomised version of this variable, in 
comparison with continuous form, improved the qual-
ity of the model.
25 Therefore in this study, only   
Table 2: Comparison of estimated HRs (95% C.I.s) corresponding to analysis of complete-case and imputed data 
sets
a 
Variable  Level  Complete-case model (N=203, 
D=54) 
Imputed data sets model
(N=310, D=56) 
HR (95% C.I.) P value HR (95% C.I.)  P value
Stage  1  1   1  
2  2.89 (1.52, 5.51)  0.001  3.13 (1.64, 5.97)  <0.001 
3 1.94  (0.81, 4.63) 0.13 2.53 (1.05, 6.12) 0.03
Grade  1  1   1 1 
2  2.46 (1.61, 5.23)  0.02  2.46 (1.15, 5.24)  0.02 
3 1.33  (0.58, 3.04) 0.50 1.52 (0.65, 3.60) 0.34
Age  <48  1   1 1 
≥48  1.75 (0.91, 3.38)  0.10  1.92 (1.01, 3.65)  0.04 
Benign No  1  1
Yes  1.91 (1.04, 3.49)  0.04  2.32 (1.24, 4.33)  0.01 
Performance of models 
C-index 72%  76%
Likelihood Ratio Test  32.44  51.19 
a HR: Hazard Ratio, C.I.: Confidence Interval, N: Sample size, D: Number of deaths Baneshi et al. 
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information on 2 binary and 2 categorical variables were 
analysed. When continuous data are available, Predictive 
Mean Matching (PMM) technique can be employed. In 
the PMM method, the complete-case whose value is 
closest to the imputed value is chosen. It takes the obser-
vation from the complete-case as the imputed value. 
Our work involved several limitations. We used a 
data set contained only four variables. Therefore, impact 
of number of variables offered to the multifactorial 
model was not investigated. Furthermore, we only com-
pared performance of the C-C and the MICE at 35% 
missing rate and under MAR mechanism. It is known 
that performance of models depends to a great extent to 
mechanism of missing data, rate of missing data, meth-
od of imputation of missing data, and sample size.
26-29 
Our work was simply a case study to explain the meth-
odological issues in the application of the MICE meth-
od, and its art in recovery of information. 
Therefore, it is needed to design future studies so 
as to compare the performance of imputation models 
under different scenarios (i.e. by changing the sample 
size, missingness mechanism, missing rate, and 
method of imputation). We already showed that the 
C-C model decreases the power and the MICE meth-
od recovers the data. However, at this stage, due to 
limitations listed above, we cannot provide a   
specific guideline on how best to tackle the problem 
of missing data because there are lots of approaches 
to deal with missing data.
30 It has been shown that 
under special circumstances, alternative methods with 
easier methodology (such as replacement of missing 
data by mean of observed values) might provide 
comparable estimates. Application and comparison of 
alternative imputation methods were beyond the 
scope of this paper and will be published elsewhere. 
Results presented showed how exclusion of missing 
data affect the composition of the model. Application of 
ad hoc methods such as complete case analysis is hugely 
criticised.
31,32 When complete-case gives results compa-
rable to that of the MICE method, a gold standard such 
as the MICE method is required to compare results with 
other simpler methods. Therefore, application of such 
methods is highly recommended. 
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